Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14160
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pingaew R. | |
dc.contributor.author | Prachayasittikul S. | |
dc.contributor.author | Ruchirawat S. | |
dc.contributor.author | Prachayasittikul V. | |
dc.date.accessioned | 2021-04-05T03:33:23Z | - |
dc.date.available | 2021-04-05T03:33:23Z | - |
dc.date.issued | 2013 | |
dc.identifier.issn | 10542523 | |
dc.identifier.other | 2-s2.0-84872013061 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14160 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872013061&doi=10.1007%2fs00044-012-0025-y&partnerID=40&md5=d4d999d10fb45e5c51532ddca15824f7 | |
dc.description.abstract | The modified Pictet-Spengler reaction of phenylethylbenzene sulfonamide with a commercially available glyoxal to construct 1-benzoyl- and 1-acetyl-1,2,3,4-tetrahydroisoquinolines 9a-n has been reported. The reaction could be accomplished, regardless of the oxygenation pattern on the aromatic ring, leading to the N-sulfonyltetrahydroisoquinoline analogs which are versatile intermediates for the synthesis of new thiosemicarbazone analogs of 1,2,3,4-tetrahydroisoquinoline. Bioactivity test revealed that most thiosemicarbazones displayed cytotoxic potency against MOLT-3 cell lines with an IC50 less than 20 μg/mL. Significantly, the thiosemicarbazone analog of 1-acetyltetrahydroisoquinoline 9j was the most potent cytotoxic compound against HuCCA-1, HepG2, and MOLT-3 cells. This study provides the novel lead molecules for further development. © 2012 Springer Science+Business Media, LLC. | |
dc.subject | 1 acetyl 6,7 dimethoxy n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 acetyl 6,7 dimethoxy n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 acetyl n 3 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 acetyl n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 acetyl n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl 6,7 dimethoxy n 4 chlorobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl 6,7 dimethoxy n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl 6,7 dimethoxy n 4 methylbenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl 6,7 dimethoxy n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl n 4 methoxybenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl n 4 methylbenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | 1 benzoyl n 4 nitrobenzenesulfonyl 1,2,3,4 tetrahydroisoquinoline thiosemicarbazone | |
dc.subject | antineoplastic agent | |
dc.subject | doxorubicin | |
dc.subject | etoposide | |
dc.subject | thiosemicarbazone derivative | |
dc.subject | unclassified drug | |
dc.subject | antineoplastic activity | |
dc.subject | article | |
dc.subject | controlled study | |
dc.subject | cytotoxicity | |
dc.subject | drug activity | |
dc.subject | drug potency | |
dc.subject | drug synthesis | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | IC 50 | |
dc.subject | oxygenation | |
dc.subject | Pictet Spengler reaction | |
dc.title | Synthesis and cytotoxicity of novel N-sulfonyl-1,2,3,4- tetrahydroisoquinoline thiosemicarbazone derivatives | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Medicinal Chemistry Research. Vol 22, No.1 (2013), p.267-277 | |
dc.identifier.doi | 10.1007/s00044-012-0025-y | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.